The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Myeloid-Derived Suppressor Cells in Tumors: From Mechanisms to Antigen Specificity and Microenvironmental Regulation
Open accessAbstract
Among the various immunological and non-immunological tumor-promoting activities of myeloid-derived suppressor cells (MDSCs), their immunosuppressive capacity remains a key hallmark. Effort in the past decade has provided us with a clearer view of the suppressive nature of MDSCs. More suppressive pathways have been identified, and their recognized targets have been expanded from T cells and natural killer (NK) cells to other immune cells. These novel mechanisms and targets afford MDSCs versatility in suppressing both innate and adaptive immunity. On the other hand, a better understanding of the regulation of their development and function has been unveiled. This intricate regulatory network, consisting of tumor cells, stromal cells, soluble mediators, and hostile physical conditions, reveals bi-directional crosstalk between MDSCs and the tumor microenvironment. In this article, we will review available information on how MDSCs exert their immunosuppressive function and how they are regulated in the tumor milieu. As MDSCs are a well-established obstacle to anti-tumor immunity, new insights in the potential synergistic combination of MDSC-targeted therapy and immunotherapy will be discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Aberrant frequency of IL-35 producing B cells in colorectal cancer patients
Wang, K., Gong, H., Chai, R., Yuan, H., Chen, Y., & Liu, J. (2018) · Cytokine · doi:10.1016/j.cyto.2017.10.011 · Cited by 13
RetractedRecommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Bronte, V., Brandau, S., Chen, S.-H., Colombo, M. P., Frey, A. B., Greten, T. F., Mandruzzato, S., Murray, P. J., Ochoa, A., Ostrand-Rosenberg, S., et al. (2016) · Nature Communications · doi:10.1038/ncomms12150 · Cited by 2,751
Noman, M. Z., Desantis, G., Janji, B., Hasmim, M., Karray, S., Dessen, P., Bronte, V., & Chouaib, S. (2014) · Journal of Experimental Medicine · doi:10.1084/jem.20131916 · Cited by 2,166
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kumar, V., Patel, S., Tcyganov, E., & Gabrilovich, D. I. (2016) · Trends in Immunology · doi:10.1016/j.it.2016.01.004 · Cited by 2,008
Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
Youn, J.-I., Nagaraj, S., Collazo, M., & Gabrilovich, D. I. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5791 · Cited by 1,645
Huang, B., Pan, P.-Y., Li, Q., Sato, A. I., Levy, D. E., Bromberg, J., Divino, C. M., & Chen, S.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1299 · Cited by 1,435
Movahedi, K., Guilliams, M., Van den Bossche, J., Van den Bergh, R., Gysemans, C., Beschin, A., De Baetselier, P., & Van Ginderachter, J. A. (2008) · Blood · doi:10.1182/blood-2007-07-099226 · Cited by 1,234
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Nagaraj, S., Gupta, K., Pisarev, V., Kinarsky, L., Sherman, S., Kang, L., Herber, D. L., Schneck, J., & Gabrilovich, D. I. (2007) · Nature Medicine · doi:10.1038/nm1609 · Cited by 1,174
Corzo, C. A., Condamine, T., Lu, L., Cotter, M. J., Youn, J.-I., Cheng, P., Cho, H.-I., Celis, E., Quiceno, D. G., Padhya, T., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100587 · Cited by 1,173
Chalmin, F., Ladoire, S., Mignot, G., Vincent, J., Bruchard, M., Remy-Martin, J.-P., Boireau, W., Rouleau, A., Simon, B., Lanneau, D., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40483 · Cited by 998
Myeloid-Derived Suppressor Cells Inhibit T-Cell Activation by Depleting Cystine and Cysteine
Srivastava, M. K., Sinha, P., Clements, V. K., Rodriguez, P., & Ostrand-Rosenberg, S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2587 · Cited by 949
ER Stress Sensor XBP1 Controls Anti-tumor Immunity by Disrupting Dendritic Cell Homeostasis
Cubillos-Ruiz, J. R., Silberman, P. C., Rutkowski, M. R., Chopra, S., Perales-Puchalt, A., Song, M., Zhang, S., Bettigole, S. E., Gupta, D., Holcomb, K., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.025 · Cited by 933 · cited 1×
“ER stress and XBP1 activation in tumor-infiltrating DCs lead to abnormal lipid accumulation, which impairs their antigen presentation capacity (201).”
BackgroundCheng, P., Corzo, C. A., Luetteke, N., Yu, B., Nagaraj, S., Bui, M. M., Ortiz, M., Nacken, W., Sorg, C., Vogl, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080132 · Cited by 902
Tumorigenic and Immunosuppressive Effects of Endoplasmic Reticulum Stress in Cancer
Cubillos-Ruiz, J. R., Bettigole, S. E., & Glimcher, L. H. (2017) · Cell · doi:10.1016/j.cell.2016.12.004 · Cited by 895
Kusmartsev, S., Nefedova, Y., Yoder, D., & Gabrilovich, D. I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.989 · Cited by 850
Sinha, P., Clements, V. K., Bunt, S. K., Albelda, S. M., & Ostrand-Rosenberg, S. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.2.977 · Cited by 847
The Terminology Issue for Myeloid-Derived Suppressor Cells
Gabrilovich, D. I., Bronte, V., Chen, S.-H., Colombo, M. P., Ochoa, A., Ostrand-Rosenberg, S., & Schreiber, H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3037 · Cited by 835
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Hoechst, B., Ormandy, L. A., Ballmaier, M., Lehner, F., Krüger, C., Manns, M. P., Greten, T. F., & Korangy, F. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.020 · Cited by 793
Condamine, T., Dominguez, G. A., Youn, J.-I., Kossenkov, A. V., Mony, S., Alicea-Torres, K., Tcyganov, E., Hashimoto, A., Nefedova, Y., Lin, C., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aaf8943 · Cited by 789
Li, H., Han, Y., Guo, Q., Zhang, M., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.240 · Cited by 777
Ghiringhelli, F., Puig, P. E., Roux, S., Parcellier, A., Schmitt, E., Solary, E., Kroemer, G., Martin, F., Chauffert, B., & Zitvogel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050463 · Cited by 776
Yang, X., Lin, Y., Shi, Y., Li, B., Liu, W., Yin, W., Dang, Y., Chu, Y., Fan, J., & He, R. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2973 · Cited by 748
Proinflammatory S100 Proteins Regulate the Accumulation of Myeloid-Derived Suppressor Cells
Sinha, P., Okoro, C., Foell, D., Freeze, H. H., Ostrand-Rosenberg, S., & Srikrishna, G. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4666 · Cited by 725
Metabolic Reprogramming of Immune Cells in Cancer Progression
Biswas, S. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.09.001 · Cited by 721
Rodríguez, P. C., & Ochoa, A. C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00608.x · Cited by 719
Serafini, P., Mgebroff, S., Noonan, K., & Borrello, I. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6621 · Cited by 673
Kumar, V., Donthireddy, L., Marvel, D., Condamine, T., Wang, F., Lavilla-Alonso, S., Hashimoto, A., Vonteddu, P., Behera, R., Goins, M. A., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.10.005 · Cited by 653
Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells
Molon, B., Ugel, S., Del Pozzo, F., Soldani, C., Zilio, S., Avella, D., De Palma, A., Mauri, P., Monegal, A., Rescigno, M., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20101956 · Cited by 650
Filipazzi, P., Valenti, R., Huber, V., Pilla, L., Canese, P., Iero, M., Castelli, C., Mariani, L., Parmiani, G., & Rivoltini, L. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.5829 · Cited by 647
Hoechst, B., Voigtlaender, T., Ormandy, L., Gamrekelashvili, J., Zhao, F., Wedemeyer, H., Lehner, F., Manns, M. P., Greten, T. F., & Korangy, F. (2009) · Hepatology · doi:10.1002/hep.23054 · Cited by 643
Chang, A. L., Miska, J., Wainwright, D. A., Dey, M., Rivetta, C. V., Yu, D., Kanojia, D., Pituch, K. C., Qiao, J., Pytel, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0144 · Cited by 640
Arginase I in myeloid suppressor cells is induced by COX-2 in lung carcinoma
Rodriguez, P. C., Hernandez, C. P., Quiceno, D., Dubinett, S. M., Zabaleta, J., Ochoa, J. B., Gilbert, J., & Ochoa, A. C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050715 · Cited by 609
Wu, P., Wu, D., Ni, C., Ye, J., Chen, W., Hu, G., Wang, Z., Wang, C., Zhang, Z., Xia, W., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.03.013 · Cited by 608
Yu, J., Du, W., Yan, F., Wang, Y., Li, H., Cao, S., Yu, W., Shen, C., Liu, J., & Ren, X. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201449 · Cited by 606
Induction of myeloid‐derived suppressor cells by tumor exosomes
Xiang, X., Poliakov, A., Liu, C., Liu, Y., Deng, Z., Wang, J., Cheng, Z., Shah, S. V., Wang, G., Zhang, L., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24249 · Cited by 598
Hossain, F., Al-Khami, A. A., Wyczechowska, D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0036 · Cited by 588
Ostrand-Rosenberg, S., Sinha, P., Beury, D. W., & Clements, V. K. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.011 · Cited by 583
Lechner, M. G., Liebertz, D. J., & Epstein, A. L. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000901 · Cited by 582
Exosomes and tumor-mediated immune suppression
Whiteside, T. L. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81136 · Cited by 569
Terabe, M., Matsui, S., Park, J.-M., Mamura, M., Noben-Trauth, N., Donaldson, D. D., Chen, W., Wahl, S. M., Ledbetter, S., Pratt, B., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20022227 · Cited by 539
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
Gabrilovich, D. I., Velders, M. P., Sotomayor, E. M., & Kast, W. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5398 · Cited by 538
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors
Weber, R., Fleming, V., Hu, X., Nagibin, V., Groth, C., Altevogt, P., Utikal, J., & Umansky, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01310 · Cited by 538
Ostrand-Rosenberg, S., & Fenselau, C. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701019 · Cited by 509
Reactive Oxygen Species in the Immune System
Yang, Y., Bazhin, A. V., Werner, J., & Karakhanova, S. (2013) · International Reviews of Immunology · doi:10.3109/08830185.2012.755176 · Cited by 509
Self-citationPrima, V., Kaliberova, L. N., Kaliberov, S., Curiel, D. T., & Kusmartsev, S. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612920114 · Cited by 494
Tumor-Expressed IDO Recruits and Activates MDSCs in a Treg-Dependent Manner
Holmgaard, R. B., Zamarin, D., Li, Y., Gasmi, B., Munn, D. H., Allison, J. P., Merghoub, T., & Wolchok, J. D. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.08.077 · Cited by 482
Bingisser, R. M., Tilbrook, P. A., Holt, P. G., & Kees, U. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.12.5729 · Cited by 480
Pan, P.-Y., Ma, G., Weber, K. J., Ozao-Choy, J., Wang, G., Yin, B., Divino, C. M., & Chen, S.-H. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1882 · Cited by 467
Chiu, D. K.-C., Tse, A. P.-W., Xu, I. M.-J., Di Cui, J., Lai, R. K.-H., Li, L. L., Koh, H.-Y., Tsang, F. H.-C., Wei, L. L., Wong, C.-M., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00530-7 · Cited by 448 · cited 1×
“The homeostasis of tumor-infiltrating MDSCs is fine-tuned by the hypoxic microenvironment, since hypoxia promotes the differentiation of intratumoral MDSCs to TAMs (190), while it is also reported that hypoxia promotes the maintenance of MDSCs by upregulating ectonucleoside triphosphate diphosphohydrolas 2 in tumor ce…”
BackgroundLi, W., Tanikawa, T., Kryczek, I., Xia, H., Li, G., Wu, K., Wei, S., Zhao, L., Vatan, L., Wen, B., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.04.022 · Cited by 446
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression
Fleming, V., Hu, X., Weber, R., Nagibin, V., Groth, C., Altevogt, P., Utikal, J., & Umansky, V. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00398 · Cited by 443
Schlecker, E., Stojanovic, A., Eisen, C., Quack, C., Falk, C. S., Umansky, V., & Cerwenka, A. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201018 · Cited by 438
Myeloid-Derived Suppressor Cells Down-Regulate L-Selectin Expression on CD4+ and CD8+ T Cells
Hanson, E. M., Clements, V. K., Sinha, P., Ilkovitch, D., & Ostrand-Rosenberg, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0804253 · Cited by 427
Alizadeh, D., Trad, M., Hanke, N. T., Larmonier, C. B., Janikashvili, N., Bonnotte, B., Katsanis, E., & Larmonier, N. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-1545 · Cited by 416
Mechanism of T Cell Tolerance Induced by Myeloid-Derived Suppressor Cells
Nagaraj, S., Schrum, A. G., Cho, H.-I., Celis, E., & Gabrilovich, D. I. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902661 · Cited by 414
Mace, T. A., Ameen, Z., Collins, A., Wojcik, S., Mair, M., Young, G. S., Fuchs, J. R., Eubank, T. D., Frankel, W. L., Bekaii-Saab, T., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4601 · Cited by 410
Boosting antitumor responses of T lymphocytes infiltrating human prostate cancers
Bronte, V., Kasic, T., Gri, G., Gallana, K., Borsellino, G., Marigo, I., Battistini, L., Iafrate, M., Prayer-Galetti, T., Pagano, F., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042028 · Cited by 396
Lesokhin, A. M., Hohl, T. M., Kitano, S., Cortez, C., Hirschhorn-Cymerman, D., Avogadri, F., Rizzuto, G. A., Lazarus, J. J., Pamer, E. G., Houghton, A. N., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-1792 · Cited by 378
Toh, B., Wang, X., Keeble, J., Sim, W. J., Khoo, K., Wong, W.-C., Kato, M., Prevost-Blondel, A., Thiery, J.-P., & Abastado, J.-P. (2011) · PLoS Biology · doi:10.1371/journal.pbio.1001162 · Cited by 369
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Lu, T., Ramakrishnan, R., Altiok, S., Youn, J.-I., Cheng, P., Celis, E., Pisarev, V., Sherman, S., Sporn, M. B., & Gabrilovich, D. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45862 · Cited by 367
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.
Condamine, T., Kumar, V., Ramachandran, I. R., Youn, J.-I., Celis, E., Finnberg, N., El-Deiry, W. S., Winograd, R., Vonderheide, R. H., English, N. R., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci74056 · Cited by 365
Sceneay, J., Chow, M. T., Chen, A., Halse, H. M., Wong, C. S. F., Andrews, D. M., Sloan, E. K., Parker, B. S., Bowtell, D. D., Smyth, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3873 · Cited by 364
Priceman, S. J., Sung, J. L., Shaposhnik, Z., Burton, J. B., Torres-Collado, A. X., Moughon, D. L., Johnson, M., Lusis, A. J., Cohen, D. A., Iruela-Arispe, M. L., et al. (2010) · Blood · doi:10.1182/blood-2009-08-237412 · Cited by 356
Al-Khami, A. A., Zheng, L., Del Valle, L., Hossain, F., Wyczechowska, D., Zabaleta, J., Sanchez, M. D., Dean, M. J., Rodriguez, P. C., & Ochoa, A. C. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1344804 · Cited by 346
CD80 in Immune Suppression by Mouse Ovarian Carcinoma–Associated Gr-1+CD11b+ Myeloid Cells
Yang, R., Cai, Z., Zhang, Y., Yutzy, W. H., Roby, K. F., & Roden, R. B. S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3755 · Cited by 343
Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host
Liu, C., Yu, S., Kappes, J., Wang, J., Grizzle, W. E., Zinn, K. R., & Zhang, H.-G. (2007) · Blood · doi:10.1182/blood-2006-09-046201 · Cited by 335
Elkabets, M., Ribeiro, V. S. G., Dinarello, C. A., Ostrand‐Rosenberg, S., Di Santo, J. P., Apte, R. N., & Vosshenrich, C. A. J. (2010) · European Journal of Immunology · doi:10.1002/eji.201041037 · Cited by 319
Tumor-Associated CD8+ T Cell Tolerance Induced by Bone Marrow-Derived Immature Myeloid Cells
Kusmartsev, S., Nagaraj, S., & Gabrilovich, D. I. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4583 · Cited by 310
Lenalidomide Enhances Immune Checkpoint Blockade-Induced Immune Response in Multiple Myeloma
Görgün, G., Samur, M. K., Cowens, K. B., Paula, S., Bianchi, G., Anderson, J. E., White, R. E., Singh, A., Ohguchi, H., Suzuki, R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0200 · Cited by 309
Cekic, C., Day, Y.-J., Sag, D., & Linden, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3583 · Cited by 304
Li, J., Wang, L., Chen, X., Li, L., Li, Y., Ping, Y., Huang, L., Yue, D., Zhang, Z., Wang, F., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1320011 · Cited by 299
Raber, P. L., Thevenot, P., Sierra, R., Wyczechowska, D., Halle, D., Ramirez, M. E., Ochoa, A. C., Fletcher, M., Velasco, C., Wilk, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28622 · Cited by 297
Transmission of endoplasmic reticulum stress and pro-inflammation from tumor cells to myeloid cells
Mahadevan, N. R., Rodvold, J., Sepulveda, H., Rossi, S., Drew, A. F., & Zanetti, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1008942108 · Cited by 294
The Biodistribution and Immune Suppressive Effects of Breast Cancer–Derived Exosomes
Wen, S. W., Sceneay, J., Lima, L. G., Wong, C. S. F., Becker, M., Krumeich, S., Lobb, R. J., Castillo, V., Wong, K. N., Ellis, S., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0868 · Cited by 289
Guo, X., Qiu, W., Liu, Q., Qian, M., Wang, S., Zhang, Z., Gao, X., Chen, Z., Xue, H., & Li, G. (2018) · Oncogene · doi:10.1038/s41388-018-0261-9 · Cited by 287
Dugast, A.-S., Haudebourg, T., Coulon, F., Heslan, M., Haspot, F., Poirier, N., Vuillefroy de Silly, R., Usal, C., Smit, H., Martinet, B., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.12.7898 · Cited by 279
Zhang, H., Ye, Y.-L., Li, M.-X., Ye, S.-B., Huang, W.-R., Cai, T.-T., He, J., Peng, J.-Y., Duan, T.-H., Cui, J., et al. (2017) · Oncogene · doi:10.1038/onc.2016.367 · Cited by 278
Bunt, S. K., Clements, V. K., Hanson, E. M., Sinha, P., & Ostrand-Rosenberg, S. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0708446 · Cited by 277
Extracellular vesicle-mediated transfer of functional RNA in the tumor microenvironment
Ridder, K., Sevko, A., Heide, J., Dams, M., Rupp, A.-K., Macas, J., Starmann, J., Tjwa, M., Plate, K. H., Sültmann, H., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008371 · Cited by 276
Mao, Y., Sarhan, D., Steven, A., Seliger, B., Kiessling, R., & Lundqvist, A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0635 · Cited by 274
Li, L., Wang, L., Li, J., Fan, Z., Yang, L., Zhang, Z., Zhang, C., Yue, D., Qin, G., Zhang, T., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2460 · Cited by 266
Limagne, E., Euvrard, R., Thibaudin, M., Rébé, C., Derangère, V., Chevriaux, A., Boidot, R., Végran, F., Bonnefoy, N., Vincent, J., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3164 · Cited by 264
Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells
Ryzhov, S., Novitskiy, S. V., Goldstein, A. E., Biktasova, A., Blackburn, M. R., Biaggioni, I., Dikov, M. M., & Feoktistov, I. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101225 · Cited by 261
Thevenot, P. T., Sierra, R. A., Raber, P. L., Al-Khami, A. A., Trillo-Tinoco, J., Zarreii, P., Ochoa, A. C., Cui, Y., Del Valle, L., & Rodriguez, P. C. (2014) · Immunity · doi:10.1016/j.immuni.2014.08.015 · Cited by 254
Arihara, F., Mizukoshi, E., Kitahara, M., Takata, Y., Arai, K., Yamashita, T., Nakamoto, Y., & Kaneko, S. (2013) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-013-1447-1 · Cited by 252
Jitschin, R., Braun, M., Büttner, M., Dettmer-Wilde, K., Bricks, J., Berger, J., Eckart, M. J., Krause, S. W., Oefner, P. J., Le Blanc, K., et al. (2014) · Blood · doi:10.1182/blood-2013-12-546416 · Cited by 251
Stiff, A., Trikha, P., Mundy-Bosse, B., McMichael, E., Mace, T. A., Benner, B., Kendra, K., Campbell, A., Gautam, S., Abood, D., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0691 · Cited by 244
Chiu, D. K., Xu, I. M., Lai, R. K., Tse, A. P., Wei, L. L., Koh, H., Li, L. L., Lee, D., Lo, R. C., Wong, C., et al. (2016) · Hepatology · doi:10.1002/hep.28655 · Cited by 241
Parker, K. H., Sinha, P., Horn, L. A., Clements, V. K., Yang, H., Li, J., Tracey, K. J., & Ostrand-Rosenberg, S. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2347 · Cited by 241
Plasticity of human Th17 cells and iTregs is orchestrated by different subsets of myeloid cells
Hoechst, B., Gamrekelashvili, J., Manns, M. P., Greten, T. F., & Korangy, F. (2011) · Blood · doi:10.1182/blood-2010-11-317321 · Cited by 238
Inhibiting myeloid-derived suppressor cell trafficking enhances T cell immunotherapy
Sun, L., Clavijo, P. E., Robbins, Y., Patel, P., Friedman, J., Greene, S., Das, R., Silvin, C., Van Waes, C., Horn, L. A., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126853 · Cited by 237
Wang, J., De Veirman, K., Faict, S., Frassanito, M. A., Ribatti, D., Vacca, A., & Menu, E. (2016) · The Journal of Pathology · doi:10.1002/path.4712 · Cited by 231
Burga, R. A., Thorn, M., Point, G. R., Guha, P., Nguyen, C. T., Licata, L. A., DeMatteo, R. P., Ayala, A., Joseph Espat, N., Junghans, R. P., et al. (2015) · Cancer Immunology, Immunotherapy · doi:10.1007/s00262-015-1692-6 · Cited by 230
The expression profiles and regulation of PD-L1 in tumor-induced myeloid-derived suppressor cells
Lu, C., Redd, P. S., Lee, J. R., Savage, N., & Liu, K. (2016) · OncoImmunology · doi:10.1080/2162402x.2016.1247135 · Cited by 230
Deng, J., Li, J., Sarde, A., Lines, J. L., Lee, Y.-C., Qian, D. C., Pechenick, D. A., Manivanh, R., Le Mercier, I., Lowrey, C. H., et al. (2019) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-18-0507 · Cited by 224
Contribution of MyD88 to the Tumor Exosome-Mediated Induction of Myeloid Derived Suppressor Cells
Liu, Y., Xiang, X., Zhuang, X., Zhang, S., Liu, C., Cheng, Z., Michalek, S., Grizzle, W., & Zhang, H.-G. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090777 · Cited by 218
Brimnes, M. K., Vangsted, A. J., Knudsen, L. M., Gimsing, P., Gang, A. O., Johnsen, H. E., & Svane, I. M. (2010) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2010.02463.x · Cited by 215
Liu, G., Bi, Y., Shen, B., Yang, H., Zhang, Y., Wang, X., Liu, H., Lu, Y., Liao, J., Chen, X., et al. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-2584 · Cited by 199
Yan, D., Wang, H.-W., Bowman, R. L., & Joyce, J. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.035 · Cited by 194
Kohanbash, G., McKaveney, K., Sakaki, M., Ueda, R., Mintz, A. H., Amankulor, N., Fujita, M., Ohlfest, J. R., & Okada, H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-4124 · Cited by 191
Deng, Y., Cheng, J., Fu, B., Liu, W., Chen, G., Zhang, Q., & Yang, Y. (2017) · Oncogene · doi:10.1038/onc.2016.273 · Cited by 186
Self-citationBeury, D. W., Parker, K. H., Nyandjo, M., Sinha, P., Carter, K. A., & Ostrand-Rosenberg, S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0414-210r · Cited by 183
Jian, S.-L., Chen, W.-W., Su, Y.-C., Su, Y.-W., Chuang, T.-H., Hsu, S.-C., & Huang, L.-R. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.192 · Cited by 183
Brudecki, L., Ferguson, D. A., McCall, C. E., & El Gazzar, M. (2012) · Infection and Immunity · doi:10.1128/iai.00239-12 · Cited by 179
Yang, Z., Zhang, B., Li, D., Lv, M., Huang, C., Shen, G.-X., & Huang, B. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008922 · Cited by 177
Mononuclear myeloid-derived “suppressor” cells express RAE-1 and activate natural killer cells
Nausch, N., Galani, I. E., Schlecker, E., & Cerwenka, A. (2008) · Blood · doi:10.1182/blood-2008-03-143776 · Cited by 174
Siret, C., Collignon, A., Silvy, F., Robert, S., Cheyrol, T., André, P., Rigot, V., Iovanna, J., van de Pavert, S. A., Lombardo, D., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03070 · Cited by 174
Transmembrane TNF-α Promotes Suppressive Activities of Myeloid-Derived Suppressor Cells via TNFR2
Hu, X., Li, B., Li, X., Zhao, X., Wan, L., Lin, G., Yu, M., Wang, J., Jiang, X., Feng, W., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1203195 · Cited by 172
van Deventer, H. W., Burgents, J. E., Wu, Q. P., Woodford, R.-M. T., Brickey, W. J., Allen, I. C., McElvania-Tekippe, E., Serody, J. S., & Ting, J. P.-Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1921 · Cited by 172
Dubinski, D., Wölfer, J., Hasselblatt, M., Schneider-Hohendorf, T., Bogdahn, U., Stummer, W., Wiendl, H., & Grauer, O. M. (2016) · Neuro-Oncology · doi:10.1093/neuonc/nov280 · Cited by 169
Azzaoui, I., Uhel, F., Rossille, D., Pangault, C., Dulong, J., Le Priol, J., Lamy, T., Houot, R., Le Gouill, S., Cartron, G., et al. (2016) · Blood · doi:10.1182/blood-2015-08-662783 · Cited by 168
Bodogai, M., Moritoh, K., Lee-Chang, C., Hollander, C. M., Sherman-Baust, C. A., Wersto, R. P., Araki, Y., Miyoshi, I., Yang, L., Trinchieri, G., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3077 · Cited by 167
TGF-β Signaling in Myeloid Cells Is Required for Tumor Metastasis
Pang, Y., Gara, S. K., Achyut, B. R., Li, Z., Yan, H. H., Day, C., Weiss, J. M., Trinchieri, G., Morris, J. C., & Li, Y. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0527 · Cited by 166
Sinha, P., Chornoguz, O., Clements, V. K., Artemenko, K. A., Zubarev, R. A., & Ostrand‐Rosenberg, S. (2011) · Blood · doi:10.1182/blood-2010-11-321752 · Cited by 165
Domenis, R., Cesselli, D., Toffoletto, B., Bourkoula, E., Caponnetto, F., Manini, I., Beltrami, A. P., Ius, T., Skrap, M., Di Loreto, C., et al. (2017) · PLOS ONE · doi:10.1371/journal.pone.0169932 · Cited by 165
Mahadevan, N. R., Anufreichik, V., Rodvold, J. J., Chiu, K., Sepulveda, H., & Zanetti, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051845 · Cited by 163
Myeloid-derived suppressor cells inhibit T cell activation through nitrating LCK in mouse cancers
Feng, S., Cheng, X., Zhang, L., Lu, X., Chaudhary, S., Teng, R., Frederickson, C. E., Champion, M. M., Zhao, R., Liang Cheng, C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1800695115 · Cited by 162
Hu, C.-E., Gan, J., Zhang, R.-D., Cheng, Y.-R., & Huang, G.-J. (2011) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2010.516450 · Cited by 161
Wang, J., Veirman, K. D., Beule, N. D., Maes, K., Bruyne, E. D., Valckenborgh, E. V., Vanderkerken, K., & Menu, E. (2015) · Oncotarget · doi:10.18632/oncotarget.6083 · Cited by 160
Iannone, R., Miele, L., Maiolino, P., Pinto, A., & Morello, S. (2013) · Neoplasia · doi:10.1593/neo.131748 · Cited by 156
Noman, M. Z., Janji, B., Hu, S., Wu, J. C., Martelli, F., Bronte, V., & Chouaïb, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0405 · Cited by 153
Al-Khami, A. A., Hossain, F. M., Wyczechowska, D. D., Hernandez, C., Zheng, L., Reiss, K., Valle, L. D., Trillo-Tinoco, J., Maj, T., Zou, W., et al. (2015) · Journal for ImmunoTherapy of Cancer · doi:10.1186/2051-1426-3-s2-o18 · Cited by 151
Bose, A., Taylor, J. L., Alber, S. M., Watkins, S. C., García, J. A., Rini, B. I., Ko, J. S., Cohen, P. A., Finke, J. H., & Storkus, W. J. (2010) · International Journal of Cancer · doi:10.1002/ijc.25863 · Cited by 150
TGF-β Receptor II Loss Promotes Mammary Carcinoma Progression by Th17-Dependent Mechanisms
Novitskiy, S. V., Pickup, M. W., Gorska, A. E., Owens, P., Chytil, A., Aakre, M. E., Wu, H., Shyr, Y., & Moses, H. L. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0100 · Cited by 149
Regulatory T Cells Stimulate B7-H1 Expression in Myeloid-Derived Suppressor Cells in ret Melanomas
Fujimura, T., Ring, S., Umansky, V., Mahnke, K., & Enk, A. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.416 · Cited by 148
de Coaña, Y. P., Poschke, I. C., Gentilcore, G., Mao, Y., Nystrom, M. L., Hansson, J., Masucci, G. V., & Kiessling, R. W. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0016 · Cited by 146
Tumor-Induced CD11b+Gr-1+ Myeloid Cells Suppress T Cell Sensitization in Tumor-Draining Lymph Nodes
Watanabe, S., Deguchi, K., Zheng, R., Tamai, H., Wang, L.-X., Cohen, P. A., & Shu, S. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.5.3291 · Cited by 144
Chafe, S. C., Lou, Y., Sceneay, J., Vallejo, M., Hamilton, M. J., McDonald, P. C., Bennewith, K. L., Möller, A., & Dedhar, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-3000 · Cited by 142
Myeloid-derived suppressor cells impair the quality of dendritic cell vaccines
Poschke, I. C., Mao, Y., Adamson, L., Salazar‐Onfray, F., Masucci, G. V., & Kiessling, R. W. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1143-y · Cited by 139
In vivo suppressive function of myeloid‐derived suppressor cells is limited to the inflammatory site
Haverkamp, J. M., Crist, S. A., Elzey, B. D., Bozkus, C. C., & Ratliff, T. L. (2011) · European Journal of Immunology · doi:10.1002/eji.201041069 · Cited by 138
Rieber, N. P., Gille, C., Köstlin, N., Schäfer, I., Spring, B., Ost, M., Spieles, H., Kugel, H., Pfeiffer, M. M., Heininger, V., et al. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12143 · Cited by 134
Park, M., Lee, S., Kim, E., Lee, E., Park, S., Kwok, S., & Cho, M. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39767 · Cited by 134
Rodríguez‐Ubreva, J., Català‐Moll, F., Obermajer, N., Álvarez‐Errico, D., Ramírez, R. N., Vento‐Tormo, R., Moreno‐Bueno, G., Edwards, R. P., Mortazavi, A., Kaliński, P., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.09.018 · Cited by 134
Zhang, Y., Liu, Q., Zhang, M., Yu, Y., Liu, X., & Cao, X. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0801548 · Cited by 133
Knier, B., Hiltensperger, M., Sie, C., Aly, L., Lepennetier, G., Engleitner, T., Garg, G., Muschaweckh, A., Mitsdoerffer, M., Koedel, U., et al. (2018) · Nature Immunology · doi:10.1038/s41590-018-0237-5 · Cited by 133
Role of TGF-β Signaling in Generation of CD39+CD73+ Myeloid Cells in Tumors
Ryzhov, S. V., Pickup, M. W., Chytil, A., Gorska, A. E., Zhang, Q., Owens, P., Feoktistov, I., Moses, H. L., & Novitskiy, S. V. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400578 · Cited by 126
Arora, M., Poe, S. L., Oriss, T. B., Krishnamoorthy, N., Yarlagadda, M., Wenzel, S. E., Billiar, T. R., Ray, A., & Ray, P. (2010) · Mucosal Immunology · doi:10.1038/mi.2010.41 · Cited by 126
Ai, L., Mu, S., Wang, Y., Wang, H., Cai, L., Li, W., & Hu, Y. (2018) · BMC Cancer · doi:10.1186/s12885-018-5086-y · Cited by 126
IL-10 Immunomodulation of Myeloid Cells Regulates a Murine Model of Ovarian Cancer
Hart, K. M., Byrne, K. T., Molloy, M. J., Usherwood, E., & Berwin, B. L. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00029 · Cited by 124
Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5
Wang, Y., Schafer, C. C., Hough, K. P., Tousif, S., Duncan, S. R., Kearney, J. F., Ponnazhagan, S., Hsu, H., & Deshane, J. S. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701069 · Cited by 122
Bozkus, C. C., Elzey, B. D., Crist, S. A., Ellies, L. G., & Ratliff, T. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500959 · Cited by 121
Nan, J., Xing, Y., Hu, B., Tang, J., Dong, H., He, Y., Ruan, D., Ye, Q., Cai, J., Ma, X., et al. (2017) · Immunology · doi:10.1111/imm.12876 · Cited by 121
mTOR masters monocytic myeloid-derived suppressor cells in mice with allografts or tumors
Wu, T., Zhao, Y., Wang, H., Li, Y., Shao, L., Wang, R., Lu, J., Yang, Z., Wang, J., & Zhao, Y. X. (2016) · Scientific Reports · doi:10.1038/srep20250 · Cited by 120
Ku, A. W., Muhitch, J. B., Powers, C. A., Diehl, M. R., Kim, M., Fisher, D. T., Sharda, A. P., Clements, V. K., O’Loughlin, K. L., Minderman, H., et al. (2016) · eLife · doi:10.7554/elife.17375 · Cited by 119
Karakhanova, S., Link, J., Heinrich, M., Shevchenko, I., Yang, Y., Hassenpflug, M., Bunge, H., von Ahn, K., Brecht, R., Mathes, A., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.998519 · Cited by 118
Self-citationB7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer
Liu, Y., Zeng, B., Zhang, Z., Zhang, Y. C., & Yang, R. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.030 · Cited by 114
Chikamatsu, K., Sakakura, K., Toyoda, M., Takahashi, K., Yamamoto, T., & Masuyama, K. (2012) · Cancer Science · doi:10.1111/j.1349-7006.2012.02248.x · Cited by 114
Thorn, M., Guha, P., Cunetta, M., Espat, N. J., Miller, G., Junghans, R. P., & Katz, S. C. (2016) · Cancer Gene Therapy · doi:10.1038/cgt.2016.19 · Cited by 113
Yergin, C. G., Roggerson, K. M., Lee, H., Golden‐Mason, L., Rosen, H. R., & Hahn, Y. S. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1501881 · Cited by 112
Tomić, S., Joksimović, B., Bekić, M., Vasiljević, M., Milanović, M., Čolić, M. J., & Vučević, D. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00475 · Cited by 111
Schouppe, E., Mommer, C., Movahedi, K., Laoui, D., Morias, Y., Gysemans, C. A., Luyckx, A., BAETSELIER, P. D., & Ginderachter, J. A. V. (2013) · European Journal of Immunology · doi:10.1002/eji.201343349 · Cited by 110
Myeloid-derived suppressor cells regulate T cell and B cell responses during autoimmune disease
Crook, K. R., Jin, M., Weeks, M. F., Rampersad, R. R., Baldi, R. M., Glekas, A. S., Shen, Y., Esserman, D. A., Little, P., Schwartz, T. A., et al. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.4a0314-139r · Cited by 108
Diao, J., Yang, X., Song, X., Chen, S., He, Y., Wang, Q., Chen, G., Luo, C., Wu, X., & Zhang, Y. (2015) · Medical Oncology · doi:10.1007/s12032-014-0453-2 · Cited by 108
Nagaraj, S., Nelson, A., Youn, J., Cheng, P., Quiceno, D. G., & Gabrilovich, D. I. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2863 · Cited by 108
Connolly, M. K., Clair, J. M., Bedrosian, A. S., Malhotra, A., Vera, V., Ibrahim, J., Henning, J. R., Pachter, H. L., Bar‐Sagi, D., Frey, A. B., et al. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0909607 · Cited by 108
Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells
Nagaraj, S., & Gabrilovich, D. I. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2012.01.010 · Cited by 106
MIF Is Necessary for Late-Stage Melanoma Patient MDSC Immune Suppression and Differentiation
Yaddanapudi, K., Rendon, B. E., Lamont, G. J., Kim, E. J., Rayyan, N. A., Richie, J., Albeituni, S., Waigel, S. J., Wise, A. D., & Mitchell, R. A. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-15-0070-t · Cited by 106
Shen, M., Wang, J., Yu, W., Zhang, C., Liu, M., Wang, K., Yang, L., Wei, F., Wang, S. E., Sun, Q., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1413520 · Cited by 104
Gehad, A. E., Lichtman, M. K., Schmults, C. D., Teague, J. E., Calarese, A. W., Jiang, Y., Watanabe, R., & Clark, R. A. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.190 · Cited by 103
Iwata, T., Kondo, Y., Kimura, O. S., Morosawa, T., Fujisaka, Y., Umetsu, T., Kogure, T., Inoue, J., Nakagome, Y., & Shimosegawa, T. (2016) · Scientific Reports · doi:10.1038/srep39296 · Cited by 103
Lee, B., Chang, S.-Y., Hong, E.-H., Kwon, B.-E., Kim, H. M., Kim, Y., Lee, J., Cho, H., Cheon, J. H., & Ko, H. (2014) · Oncotarget · doi:10.18632/oncotarget.2589 · Cited by 102
Markowitz, J., Wang, J., Vangundy, Z., You, J., Yildiz, V. O., Yu, L., Foote, I. P., Branson, O. E., Stiff, A. R., Brooks, T., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14970-0 · Cited by 102
Huang, A., Zhang, B., Yan, W., Wang, B., Wei, H., Zhang, F., Wu, L., Fan, K., & Guo, Y. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400849 · Cited by 97
Inhibition of B Lymphopoiesis by Adipocytes and IL-1–Producing Myeloid-Derived Suppressor Cells
Kennedy, D. E., & Knight, K. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500957 · Cited by 97
Mauti, L. A., Bitoux, M. L., Baumer, K., Stehle, J., Golshayan, D., Provero, P., & Stamenkovic, I. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41936 · Cited by 97
Ohshio, Y., Teramoto, K., Hanaoka, J., Tezuka, N., Itoh, Y., Asai, T., Daigo, Y., & Ogasawara, K. (2014) · Cancer Science · doi:10.1111/cas.12584 · Cited by 95
Li, A., Chen, P., Leng, Y., & Kang, J. (2018) · Oncogene · doi:10.1038/s41388-018-0379-9 · Cited by 92
Expression of checkpoint molecules on myeloid-derived suppressor cells
Ballbach, M., Dannert, A., Singh, A., Siegmund, D. M., Handgretinger, R., Piali, L., Rieber, N. P., & Hartl, D. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.10.001 · Cited by 91
Chen, X., Wang, L., Li, P., Song, M., Qin, G., Gao, Q., Zhang, Z., Yue, D., Wang, D., Nan, S., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31730 · Cited by 91
Xiao, W. L., Klement, J. D., Lu, C., Ibrahim, M. L., & Liu, K. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800129 · Cited by 90
Centuori, S. M., Trad, M., LaCasse, C. J., Alizadeh, D., Larmonier, C. B., Hanke, N. T., Kartchner, J., Janikashvili, N., Bonnotte, B., Larmonier, N., et al. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0911465 · Cited by 89
Zhang, C., Wang, S., Li, J., Zhang, W., Zheng, L., Yang, C., Zhu, T., & Rong, R. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.86 · Cited by 87
The Ribosomal Protein S19 Suppresses Antitumor Immune Responses via the Complement C5a Receptor 1
Markiewski, M. M., Vadrevu, S. K., Sharma, S., Chintala, N. K., Ghouse, S. M., Cho, J., Fairlie, D. P., Paterson, Y. Y. W., Astrinidis, A., & Karbowniczek, M. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602057 · Cited by 84
Maenhout, S. K., Lint, S. V., Emeagi, P. U., Thielemans, K., & Aerts, J. L. (2013) · International Journal of Cancer · doi:10.1002/ijc.28449 · Cited by 82
Lu, Y., Liu, H., Bi, Y., Yang, H., Li, Y., Wang, J., Zhang, Z., Wang, Y., Li, C., Jia, A., et al. (2017) · Cellular and Molecular Immunology · doi:10.1038/cmi.2017.5 · Cited by 80
Self-citationTumor- and organ-dependent infiltration by myeloid-derived suppressor cells
Younos, I., Donkor, M. K., Hoke, T. A., Dafferner, A. J., Samson, H., Westphal, S. N., & Talmadge, J. E. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2011.02.021 · Cited by 79
Shime, H., Maruyama, A., Yoshida, S., Takeda, Y., Matsumoto, M., & Seya, T. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1373231 · Cited by 77
TIPE2 specifies the functional polarization of myeloid-derived suppressor cells during tumorigenesis
Yan, D., Wang, J., Sun, H., Zamani, A., Zhang, H., Chen, W., Tang, A., Ruan, Q., Yang, X., Chen, Y. H., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20182005 · Cited by 77
Danelli, L., Frossi, B., Gri, G., Mion, F., Guarnotta, C., Bongiovanni, L., Tripodo, C., Mariuzzi, L., Marzinotto, S., Rigoni, A., et al. (2014) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0102 · Cited by 76
Novel insights into exosome-induced, tumor-associated inflammation and immunomodulation
Altevogt, P., Bretz, N. P., Ridinger, J., Utikal, J. S., & Umansky, V. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.04.008 · Cited by 76
NK Cell Response to Vaccinia Virus Is Regulated by Myeloid-Derived Suppressor Cells
Fortin, C. F., Huang, X., & Yang, Y. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200584 · Cited by 76
Self-citationRole of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells
Hong, J., Tobin, N. P., Rundqvist, H., Li, T., Lavergne, M., García-Ibáñez, Y., Qin, H., Paulsson, J., Zeitelhofer, M., Adzemovic, M. Z., et al. (2015) · Journal of the National Cancer Institute · doi:10.1093/jnci/djv209 · Cited by 75 · cited 1×
“For instance, hypoxia facilitates the recruitment of MDSCs to tumor site (188, 189).”
BackgroundGr‐1+CD11b+ cells are responsible for tumor promoting effect of TGF‐β in breast cancer progression
Li, Z., Pang, Y., Gara, S. K., Achyut, B. R., Heger, C. D., Goldsmith, P. K., Lonning, S. M., & Yang, H. H. (2012) · International Journal of Cancer · doi:10.1002/ijc.27572 · Cited by 75
Hammami, I., Chen, J., Murschel, F., Bronte, V., Crescenzo, G. D., & Jolicœur, M. (2012) · BMC Cell Biology · doi:10.1186/1471-2121-13-18 · Cited by 74
Kuonen, F., Laurent, J., Secondini, C., Lorusso, G., Stehle, J., Rausch, T., Hull, E. F.-V., Bieler, G., Alghisi, G., Schwendener, R. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3028 · Cited by 74
Ye, C., Geng, Z., Dominguez, D., Chen, S., Fan, J., Qin, L., Long, A., Zhang, Y., Kuzel, T. M., & Zhang, B. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500729 · Cited by 74
Sayed, M. F. A., Amrein, M. A., Bührer, E. D., Huguenin, A.-L., Radpour, R., Riether, C., & Ochsenbein, A. F. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3026 · Cited by 74
Wang, L., Zhao, J., Ren, J. P., Wu, X. Y., Morrison, Z. D., Gazzar, M. E., Ning, S., Moorman, J. P., & Yao, Z. Q. (2016) · AIDS · doi:10.1097/qad.0000000000001083 · Cited by 73
Ghansah, T., Vohra, N. A., Kinney, K., Weber, A. M., Kodumudi, K. N., Springett, G. M., Sarnaik, A. A., & Pilon‐Thomas, S. (2013) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-013-1407-9 · Cited by 72
Sido, J. M., Yang, X., Nagarkatti, P. S., & Nagarkatti, M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.1a1014-479r · Cited by 71
Extracellular adenosine metabolism in immune cells in melanoma
Umansky, V., Shevchenko, I., Bazhin, A. V., & Utikal, J. S. (2014) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-014-1553-8 · Cited by 69
Self-citationGünaydın, G., Kesikli, S. A., & Güç, D. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1034918 · Cited by 67
Younis, R., Han, K., & Webb, T. (2016) · Journal of Immunology · doi:10.4049/jimmunol.1501293 · Cited by 67
Jachetti, E., Cancila, V., Rigoni, A., Bongiovanni, L., Cappetti, B., Belmonte, B., Enriquez, C., Casalini, P., Ostano, P., Frossi, B., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0385 · Cited by 67
Combined vaccine+axitinib therapy yields superior antitumor efficacy in a murine melanoma model
Bose, A., Lowe, D. B., Rao, A., & Storkus, W. J. (2012) · Melanoma Research · doi:10.1097/cmr.0b013e3283538293 · Cited by 66
Vandenberk, L., Garg, A. D., Verschuere, T., Koks, C., Belmans, J., Beullens, M., Agostinis, P., Vleeschouwer, S. D., & Gool, S. V. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1083669 · Cited by 64
Tumor Microenvironmental Conversion of Natural Killer Cells into Myeloid-Derived Suppressor Cells
Park, Y.-J., Song, B., Kim, Y.-S., Kim, E., Lee, J.-M., Lee, G.-E., Kim, J., Kim, Y., Chang, W., & Kang, C. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0545 · Cited by 63
Deng, Y., Yang, J., Luo, F., Qian, J., Liu, R., Zhang, D., Yu, H., & Chu, Y. (2018) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-018-2177-1 · Cited by 60
Zhang, G., Huang, H., Zhu, Y., Yu, G., Gao, X., Xu, Y., Liu, C., Hou, J., & Zhang, X. (2015) · OncoImmunology · doi:10.4161/2162402x.2014.977164 · Cited by 58
Cited by
Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer
Li, K., Shi, H., Zhang, B., Ou, X., Ma, Q., Chen, Y., Shu, P., Li, D., & Wang, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00670-9 · Cited by 988
Maalej, K. M., Merhi, M., Inchakalody, V. P., Mestiri, S., Alam, M., Maccalli, C., Cherif, H., Uddin, S., Steinhoff, M., Marincola, F. M., et al. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01723-z · Cited by 618
T cell receptor (TCR) signaling in health and disease
Shah, K., Al-Haidari, A., Sun, J., & Kazi, J. U. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00823-w · Cited by 604
The Evasion Mechanisms of Cancer Immunity and Drug Intervention in the Tumor Microenvironment
Kim, S. K., & Cho, S. W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.868695 · Cited by 460
Tumor Immune Microenvironment during Epithelial–Mesenchymal Transition
Taki, M., Abiko, K., Ukita, M., Murakami, R., Yamanoi, K., Yamaguchi, K., Hamanishi, J., Baba, T., Matsumura, N., & Mandai, M. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4459 · Cited by 351
Metadata
- Authors
- Yang, Y., Li, C., Liu, T., Dai, X., & Bazhin, A. V.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-07-22
- Volume
- 11
- Pages
- 1371-1371
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3033841996
- Cited by
- 291
- References
- 227
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.